Butzke, B. (2016) “The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance”, Acta Oncologica, 55(3), pp. 318–328. doi: 10.3109/0284186X.2015.1053983.